Stenocare A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was DKK 2.73 million compared to DKK 1.64 million a year ago. Net loss was DKK 13.32 million compared to DKK 12.96 million a year ago. Basic loss per share from continuing operations was DKK 1.01 compared to DKK 1.11 a year ago.